Search
Sumario de resultados
TIpos de contenido
Fecha
-
-
OfferDesarrollador/a web
-
Offer
Analista de datos
-
-
Offer
Técnico/a
-
-
NewWeLab Barcelona and Fundación MEDINA will collaborate to expand the offer of R&D services ...
This collaboration allows combining experience and resources for the discovery and development of new therapies.
-
EventBIO-Europe 2023 - Convocatoria ICEX
El Plan de Internacionalización del sector biotecnológico de ICEX para este año 2023 (gestionado por AseBio) permite ofrecer una ayuda al registro a las empresas que participen en BIO-Europe 2023.
-
NewAseBio and EuropaBio address the challenges of the Pharmaceutical Strategy and NGTs in Eur...
During the Presidency of the Council of the European Union, Spain will lead the dialogue on these critical policies for European patients, food safety, and the green transition.
-
Press release
AseBio and EuropaBio address the challenges of the Pharmaceutical Strategy and NGTs in Eur...
During the Presidency of the Council of the European Union, Spain will lead the dialogue on these critical policies for European patients, food safety, and the green transition. "We need to find a
-
NewGENESIS Biomed opens a new office in Valencia
This new location of GENESIS Biomed in the BioHub joins the existing locations in Barcelona and Madrid.
-
CompanyVIVA IN VITRO
-
NewTagworks Pharmaceuticals Announces $64 Million in Series A Financing to Advance Click-to-R...
Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures.
-
New#NewMemberAseBio| "AseBio will keep us informed and updated on status of these markets and...
Meet KINSY our new member. We talked to Alicia Hernández, Projects and Business Development Coordinator of the company.
-
NewPositive preclinical data of ORY-4001 for the treatment of Charcot-Marie-Tooth (CMT) disea...
Comprehensively reversed disease progression symptoms in a CMT mice model.
-
New‘JAMA Neurology’ publishes the results from Phase 1b/2a clinical trial of the neuroprotect...
The results from APRIL study, previously presented at the International Stroke Conference 2023, indicate that ApTOLL showed good safety in 151 acute ischemic stroke patients.
-
NewBiotech companies’ R&D investment grows by 16% in 2022 to reach €1,038 million
In 2021, the impact on GDP of biotech companies amounted to €11,183 million, or 1% of GDP
-
-
New#BIOSPAIN2023Interview | "The main risk factor for skin cancer is exposure to ultraviolet ...
On European Skin Cancer Prevention Day, we talk to Almirall, Platinum Sponsor of BIOSPAIN2023, about the importance of prevention and the main risk factors
-
Offer
Head of Administration
-
